The top pieces of news in ophthalmology in December include acquisitions and FDA clearances.
Read the best-performing pieces of ophthalmology coverage from December below.
Rayner Surgical to acquire Omidria in deal valued at more than $1 billion
Omeros will sell Omidria to Rayner Surgical Group Limited in a transaction valued at more than $1 billion, according to a press release from Omeros. Read more.
FDA clears TearCare system for treatment of meibomian gland dysfunction
The TearCare system has received 510(k) clearance from the FDA for the treatment of meibomian gland dysfunction, according to